Eastman Chem Co (EMN) Valuation Rose While Dekabank Deutsche Girozentrale Has Cut Position

Eastman Chemical Company (NYSE:EMN) LogoInvestors sentiment decreased to 0.77 in Q4 2018. Its down 0.01, from 0.78 in 2018Q3. It dived, as 72 investors sold EMN shares while 211 reduced holdings. 80 funds opened positions while 137 raised stakes. 112.79 million shares or 1.50% more from 111.12 million shares in 2018Q3 were reported. Oppenheimer Asset Mgmt has invested 0.04% in Eastman Chemical Company (NYSE:EMN). Sumitomo Mitsui Tru Holdings holds 0.05% or 586,056 shares in its portfolio. Loring Wolcott Coolidge Fiduciary Ltd Liability Partnership Ma holds 27 shares or 0% of its portfolio. 8,243 were accumulated by Pinnacle Assocs. Mutual Of America Capital Management Ltd Llc holds 0.08% or 62,729 shares. Carret Asset Limited Liability Com, New York-based fund reported 15,159 shares. Cubist Systematic Strategies Ltd Liability Corp reported 0.07% of its portfolio in Eastman Chemical Company (NYSE:EMN). Strs Ohio has invested 0.01% in Eastman Chemical Company (NYSE:EMN). Royal Bancshares Of Canada owns 110,761 shares. State Of Tennessee Treasury Department reported 0.01% stake. Advisor Partners Ltd Liability Co holds 7,451 shares or 0.09% of its portfolio. Moreover, Usca Ria Lc has 0.09% invested in Eastman Chemical Company (NYSE:EMN). National Pension Serv holds 181,899 shares or 0.06% of its portfolio. Profit Invest Mngmt Ltd Co accumulated 13,044 shares. Quantbot Tech Ltd Partnership accumulated 0.19% or 27,131 shares.

Since December 7, 2018, it had 1 insider purchase, and 0 selling transactions for $988,335 activity.

Dekabank Deutsche Girozentrale decreased its stake in Eastman Chem Co (EMN) by 58.2% based on its latest 2018Q4 regulatory filing with the SEC. Dekabank Deutsche Girozentrale sold 183,592 shares as the company’s stock rose 5.08% with the market. The institutional investor held 131,842 shares of the major chemicals company at the end of 2018Q4, valued at $9.62M, down from 315,434 at the end of the previous reported quarter. Dekabank Deutsche Girozentrale who had been investing in Eastman Chem Co for a number of months, seems to be less bullish one the $9.87 billion market cap company. The stock decreased 1.30% or $0.94 during the last trading session, reaching $71.22. About 933,424 shares traded. Eastman Chemical Company (NYSE:EMN) has declined 17.24% since May 17, 2018 and is downtrending. It has underperformed by 21.61% the S&P500.

Dekabank Deutsche Girozentrale, which manages about $15.11B US Long portfolio, upped its stake in United Technologies Corp (NYSE:UTX) by 314,718 shares to 682,359 shares, valued at $72.45 million in 2018Q4, according to the filing. It also increased its holding in Jpmorgan Chase & Co (NYSE:JPM) by 301,088 shares in the quarter, for a total of 2.09M shares, and has risen its stake in Marathon Pete Corp (NYSE:MPC).

Analysts await Eastman Chemical Company (NYSE:EMN) to report earnings on July, 25. They expect $2.16 EPS, down 2.70 % or $0.06 from last year’s $2.22 per share. EMN’s profit will be $299.34M for 8.24 P/E if the $2.16 EPS becomes a reality. After $1.77 actual EPS reported by Eastman Chemical Company for the previous quarter, Wall Street now forecasts 22.03 % EPS growth.

More news for Eastman Chemical Company (NYSE:EMN) were recently published by: Finance.Yahoo.com, which released: “Bridgewater Associates’ Latest Moves – Yahoo Finance” on May 17, 2019. Streetinsider.com‘s article titled: “Eastman Chemical (EMN) Misses Q1 EPS by 11c – StreetInsider.com” and published on April 25, 2019 is yet another important article.

Eastman Chemical Company (NYSE:EMN) Ratings Coverage

Among 6 analysts covering Eastman Chemical (NYSE:EMN), 5 have Buy rating, 0 Sell and 1 Hold. Therefore 83% are positive. Eastman Chemical had 8 analyst reports since December 11, 2018 according to SRatingsIntel. Morgan Stanley upgraded the shares of EMN in report on Thursday, January 17 to “Overweight” rating. Cowen & Co downgraded Eastman Chemical Company (NYSE:EMN) on Wednesday, February 6 to “Market Perform” rating. Standpoint Research upgraded the stock to “Buy” rating in Wednesday, December 26 report. The firm has “Overweight” rating given on Friday, April 12 by KeyBanc Capital Markets. The stock has “Buy” rating by Nomura on Monday, April 15.

Eastman Chemical Company (NYSE:EMN) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.